Tag: Takeda

Emendo Achieved Milestone of Collaboration for Takeda’s OMNI Nuclease Program

takeda hq tokyo
Emendo Biotherapeutics announced that the company achieved the first milestone as laid out in the agreements with Takeda Pharmaceutical Company Limited, resulting in the transfer of the second half of...

Sosei & Takeda to Develop Novel Molecules

takeda
Sosei Group Corporation announces that it has entered into a strategic multi-target partnership with Takeda Pharmaceutical Company Limited, to discover, develop and commercialize novel molecules, incl...

Takeda Announced Results of the VISIBLE 2 Clinical Trials Evaluating Vedolizumab

takeda hq tokyo
Takeda Pharmaceutical Company Limited announced top-line results from the VISIBLE 2 clinical trial evaluating the efficacy and safety of an investigational subcutaneous (SC) formulation of the gut-sel...

Takeda Openes First API Manufacturing Plant outside Japan

Takeda has officially opened a new manufacturing plant at its site at Grange Castle, in Dublin, Ireland. The company CEO, government ministers and industry officials together with staff and guests ...

Takeda Announced Updated Results from its Phase IIIb/IV Clinical Trial for ADYNOVATE®

takeda
Takeda Pharmaceutical Company Limited, R&D-driven, global biopharmaceutical company with a leadership position in rare diseases, has announced updated results from its phase IIIb/IV clinical trial...

Partnership for New Parkinson’s Disease Treatment

The University of Dundee‘s Drug Discovery Unit (DDU) has announced a multi-million-pound partnership with Korean-based Bukwang Pharmaceutical Company in a bid to develop a new drug treatment for Parki...

Takeda – First Private Pharma Company to Pledge for Global Fund Replenishment

takeda
Takeda Pharmaceutical Company Limited became the first private sector company to announce a financial commitment to the Global Fund’s Sixth Replenishment. The new pledge, consisting of JP ¥ 1 billion ...

Takeda’s Entyvio® Received Approval in Japan

drugsapproved
Takeda Pharmaceutical Company Limited announced that it has obtained approval from the Ministry of Health, Labour and Welfare (MHLW) for an additional indication for Entyvio® (generic name: vedolizuma...

FDA Approved Takeda’s GATTEX

Takeda Pharmaceuticals, announced today that the US Food and Drug Administration (FDA) approved extending the indication of GATTEX (teduglutide) for injection to pediatric patients 1 year of age and o...

Takeda Chair in Global Child Health Established at LSHTM

Takeda Pharmaceutical Company Limited and the London School of Hygiene & Tropical Medicine (LSHTM) announced the establishment of the Takeda Chair in Global Child Health, endowed by a £3 million d...

Frazier Healthcare Partners and Takeda Veterans to Develop GI Drug Vonoprazan

Marking the partners' second company launch with a Takeda-discovered asset, Frazier Healthcare Partners and the Japanese pharma launched Phathom with rights to gastrointestinal drug vonoprazan. The st...

Takeda Announced Financial Results for 2018

takeda
− Excellent FY2018 results driven by key growth products and strict Opex discipline, with Legacy Takeda greatly exceeding original guidance and absorbing Shire acquisition-related costs − In FY20...

FDA Accepts Takeda’s Application for a Subcutaneous Formulation of Vedolizumab

fda
Takeda Pharmaceutical Company Limited (“Takeda”) announced that the U.S. Food & Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for a subcutaneous (SC) form...

Novartis Agreed to Pay $3.4 billion for Eye Drug Assets

Novartis AG agreed to pay $3.4 billion for eye-disease medicines that Takeda Pharmaceutical Co. is selling to shed debt after its $62 billion acquisition of Shire Plc. The main product in the deal ...

Takeda Enters Strategic Alliance with Skyhawk

takeda
US-based Skyhawk Therapeutics has formed a strategic alliance with Takeda Pharmaceutical to discover and develop small molecule drug candidates for multiple targets across neurodegenerative diseases. ...

Takeda Opened Global Research Facility in San Diego

takeda
Japan-based Takeda Pharmaceutical has opened a new 165,000ft² global research facility in San Diego of California, US. With over 250 employees, the San Diego research center will focus on lever...